Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-K, filed March 3, 2026.
- Filed
- Mar 3, 2026, 7:10 AM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-086645
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 |
|---|---|---|
| Operating lease liabilities | (1,162) | (2,256) |
| Net cash used in operating activities | (123,343) | (167,647) |
| Cash flows provided by investing activities: | ||
| Purchases of property and equipment | (138) | (157) |
| Purchases of IPR&D assets, including transaction costs | — | (36,203) |
| Purchases of investments | (231,823) | (231,986) |
| Proceeds from maturities of marketable securities | 246,000 | 344,000 |
| Net cash provided by investing activities | 14,039 | 75,654 |
Item 16. Form 10-K Summary
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s capex?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported capex of $86K in Q4 2025.
- How has Amylyx Pharmaceuticals, Inc.'s capex changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s capex increased by 330.0% year-over-year, from $20K to $86K.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s capex?
- Over 3 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s capex has grown at a -26.9% compound annual growth rate (CAGR), from $353K to $138K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude